<PAPER><mode2 name='PMC3347877' hasDoc='yes' version='597'></mode2><article xmlns:mml='http://www.w3.org/1998/Math/MathML' xmlns:xlink='http://www.w3.org/1999/xlink' article-type='research-article'><front><journal-meta><journal-id journal-id-type='nlm-ta'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='iso-abbrev'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='publisher-id'>DEE</journal-id><journal-title-group><journal-title>Dementia and Geriatric Cognitive Disorders EXTRA</journal-title></journal-title-group><issn pub-type='ppub'>1664-5464</issn><issn pub-type='epub'>1664-5464</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type='pmcid'>3347877</article-id><article-id pub-id-type='pmid'>22590471</article-id><article-id pub-id-type='doi'>10.1159/000335497</article-id><article-id pub-id-type='publisher-id'>dee-0002-0097</article-id><article-categories><subj-group subj-group-type='heading'><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title><s sid='1'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>White Matter Hyperintensities and the Course of Depressive Symptoms in Elderly People with Mild Dementia</s></article-title></title-group><contrib-group><contrib contrib-type='author'><name><surname>Soennesyn</surname><given-names>Hogne</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='cor1' ref-type='corresp'>*</xref></contrib><contrib contrib-type='author'><name><surname>Oppedal</surname><given-names>Ketil</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='aff5' ref-type='aff'><sup>e</sup></xref></contrib><contrib contrib-type='author'><name><surname>Greve</surname><given-names>Ole Jacob</given-names></name><xref rid='aff2' ref-type='aff'><sup>b</sup></xref></contrib><contrib contrib-type='author'><name><surname>Fritze</surname><given-names>Friederike</given-names></name><xref rid='aff3' ref-type='aff'><sup>c</sup></xref></contrib><contrib contrib-type='author'><name><surname>Auestad</surname><given-names>Bjørn H.</given-names></name><xref rid='aff6' ref-type='aff'><sup>f</sup></xref></contrib><contrib contrib-type='author'><name><surname>Nore</surname><given-names>Sabine P.</given-names></name><xref rid='aff7' ref-type='aff'><sup>g</sup></xref></contrib><contrib contrib-type='author'><name><surname>Beyer</surname><given-names>Mona K.</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='aff4' ref-type='aff'><sup>d</sup></xref></contrib><contrib contrib-type='author'><name><surname>Aarsland</surname><given-names>Dag</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref></contrib></contrib-group><aff id='aff1'><sup>a</sup>Centre for Age-Related Medicine, Stavanger, Bergen, Norway</aff><aff id='aff2'><sup>b</sup>Department of Radiology, Stavanger, Bergen, Norway</aff><aff id='aff3'><sup>c</sup>Department of Geriatric Psychiatry, Psychiatric Clinic, Stavanger, Bergen, Norway</aff><aff id='aff4'><sup>d</sup>The Norwegian Center for Movement Disorders, Stavanger University Hospital, Stavanger, Bergen, Norway</aff><aff id='aff5'><sup>e</sup>Department of Electrical Engineering and Computer Science, University of Stavanger, Stavanger, Bergen, Norway</aff><aff id='aff6'><sup>f</sup>Department of Mathematics and Natural Sciences, University of Stavanger, Stavanger, Bergen, Norway</aff><aff id='aff7'><sup>g</sup>Department of Section of Geriatric Medicine, Haraldsplass Deaconess University Hospital, Bergen, Norway</aff><author-notes><corresp id='cor1'>*Hogne Soennesyn, Centre for Age-Related Medicine, Stavanger University Hospital, PO Box 8100, NO–4068 Stavanger (Norway), Tel. +47 5151 3436, E-Mail <email>hogne.soennesyn@sus.no</email></corresp><fn fn-type='equal'><p>A previous version was presented in part at the International Psychogeriatrics Association 15th Congress, 8 September, 2011, The Hague, The Netherlands.</p></fn></author-notes><pub-date pub-type='collection'><season>Jan-Dec</season><year>2012</year></pub-date><pub-date pub-type='epub'><day>31</day><month>3</month><year>2012</year></pub-date><pub-date pub-type='pmc-release'><day>31</day><month>3</month><year>2012</year></pub-date><volume>2</volume><issue>1</issue><fpage>97</fpage><lpage>111</lpage><permissions><copyright-statement>Copyright © 2012 by S. Karger AG, Basel</copyright-statement><copyright-year>2012</copyright-year><license license-type='open-access' xlink:href='http://creativecommons.org/licenses/by-nc-nd/3.0/'><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (<ext-link ext-link-type='uri' xlink:href='http://creativecommons.org/licenses/by-nc-nd/3.0/'>http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on <ext-link ext-link-type='uri' xlink:href='http://www.karger.com'>http://www.karger.com</ext-link> and the terms of this license are included in any shared versions.</license-p></license></permissions><abstract><sec><title>Objectives</title><p><s sid='2'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc2>To explore the relationship between white matter hyperintensities (WMH) and the prevalence and course of depressive symptoms in mild Alzheimer's disease (AD) and Lewy body dementia. <italic>Design:</italic> This is a prospective cohort study conducted in secondary care outpatient clinics in western Norway. <italic>Subjects:</italic> The study population consisted of 77 elderly people with mild dementia diagnosed according to standardised criteria.</s></p></sec><sec><title>Methods</title><p><s sid='3'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Structured clinical interviews and physical, neurological, psychiatric, and neuropsychological examinations were performed and routine blood tests were taken.</s><s sid='4'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Depression was assessed using the depression subitem of the Neuropsychiatric Inventory and the Montgomery-Åsberg Depression Rating Scale (MADRS).</s><s sid='5'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A standardised protocol for magnetic resonance imaging scan was used, and the volumes of WMH were quantified using an automated method, followed by manual editing.</s></p></sec><sec><title>Results</title><p><s sid='6'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>The volumes of total and frontal deep WMH were significantly and positively correlated with baseline severity of depressive symptoms, and depressed patients had significantly higher volumes of total and frontal deep WMH than non-depressed patients.</s><s sid='7'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Higher volumes of WMH were also associated with having a high MADRS score and incident and persistent depression at follow-up.</s><s sid='8'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> After adjustment for potential confounders, frontal deep WMH, in addition to prior depression and non-AD dementia, were still significantly associated with baseline depressive symptoms (p = 0.015, OR 3.703, 95% CI 1.294–10.593).</s><s sid='9'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Similar results emerged for total WMH.</s></p></sec><sec><title>Conclusion</title><p><s sid='10'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>In elderly people with mild dementia, volumes of WMH, in particular frontal deep WMH, were positively correlated with baseline severity of depressive symptoms, and seemed to be associated with persistent and incident depression at follow-up.</s><s sid='11'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Further studies of the mechanisms that determine the course of depression in mild dementia are needed.</s></p></sec></abstract><kwd-group><title>Key Words</title><kwd>White matter hyperintensities</kwd><kwd>Depression</kwd><kwd>Depressive symptoms</kwd><kwd>Dementia</kwd><kwd>Elderly people</kwd></kwd-group><counts><table-count count='5'></table-count><ref-count count='44'></ref-count><page-count count='15'></page-count></counts></article-meta></front><body><sec id='sec1_1'><title>Introduction</title><p><s sid='12'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>White matter hyperintensities (WMH) are commonly found in cerebral T2-weighted magnetic resonance imaging (MRI) scans of elderly people.</s><s sid='13'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> They seem to be particularly common in depression [<xref rid='B1' ref-type='bibr'>1</xref>] and dementia [<xref rid='B2' ref-type='bibr'>2</xref>, <xref rid='B3' ref-type='bibr'>3</xref>].</s><s sid='14'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Etiologically, they have been associated with classic cardiovascular risk factors [<xref rid='B2' ref-type='bibr'>2</xref>], including hypertension [<xref rid='B4' ref-type='bibr'>4</xref>], and thus are considered to be a marker of cerebrovascular disease.</s></p><p><s sid='15'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>In previous studies of elderly people, the severity of WMH has been found to predict worsening of voiding, mobility and cognition [<xref rid='B5' ref-type='bibr'>5</xref>], as well as incident depression and depressive symptoms [<xref rid='B6' ref-type='bibr'>6</xref>, <xref rid='B7' ref-type='bibr'>7</xref>].</s><s sid='16'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The volume of WMH was associated with incident depression in a study of non-institutionalised elderly people [<xref rid='B7' ref-type='bibr'>7</xref>], and severe deep white matter lesions predicted poor outcome in elderly patients with major depressive disorder [<xref rid='B8' ref-type='bibr'>8</xref>].</s></p><p><s sid='17'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>In subjects with dementia, frontal white matter lesions have been found to be associated with higher depression scores in cross-sectional studies [<xref rid='B3' ref-type='bibr'>3</xref>, <xref rid='B9' ref-type='bibr'>9</xref>].</s><s sid='18'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, a subsequent study failed to identify an association between WMH and psychiatric or other clinical variables in patients with Alzheimer's disease (AD), using a visual scale [<xref rid='B10' ref-type='bibr'>10</xref>].</s><s sid='19'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Thus, the implications of WMH with regard to incidence and prognosis of depression in subjects with mild dementia are still unclear.</s><s sid='20'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> This is unfortunate, since depression is common in dementia [<xref rid='B11' ref-type='bibr'>11</xref>], and is associated with poorer outcome in terms of cognitive ability [<xref rid='B12' ref-type='bibr'>12</xref>], functioning [<xref rid='B13' ref-type='bibr'>13</xref>], and quality of life [<xref rid='B14' ref-type='bibr'>14</xref>].</s></p><p><s sid='21'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>The aim of our study was to explore the relationship between WMH and the longitudinal course of depressive symptoms in patients with mild dementia.</s><s sid='22'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> We hypothesised that prevalence, incidence and prognosis of depressive symptoms are related to the volume of WMH and frontal deep WMH in particular.</s><s sid='23'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Such knowledge might enable a more accurate prognosis, but also increase our understanding of the underlying aetiologies of depression in dementia, and, most importantly, provide a strategy for potential prevention and treatment of depression in dementia.</s></p><p><s sid='24'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>We have previously [<xref rid='B15' ref-type='bibr'>15</xref>] reported that depression is more common in dementia with Lewy bodies (DLB) compared to AD, and that WMH are more severe in mild AD and DLB patients than in non-demented elderly, using a novel semi-automatic volumetric analysis technique (Ketil Oppedal, Alzheimer's Association International Conference 2011).</s><s sid='25'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> A secondary aim was, therefore, to explore the association between volumetrically assessed WMH and depression in patients with Lewy body dementia (LBD) and AD separately.</s></p></sec><sec sec-type='methods' id='sec1_2'><title>Methods</title><sec id='sec2_1'><title>Subjects</title><p><s sid='26'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>We screened all referrals to the five outpatient clinics in geriatric medicine and old age psychiatry in the counties of Rogaland (Stavanger and Haugesund) and Hordaland (Bergen) in western Norway from March 2005 to March 2007 for patients with a first time diagnosis of mild dementia, i.e. a minimum Mini-Mental State Examination (MMSE) score of 20.</s><s sid='27'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> From April 2007, we selectively recruited patients with DLB and Parkinson's disease with dementia (PDD).</s><s sid='28'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Additionally, three neurology outpatient clinics in the same area were contacted, and agreed to refer new dementia cases to one of the participating centres.</s><s sid='29'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The patients and caregivers were first seen by the study clinician, who performed a structured clinical interview of demographic and clinical data.</s><s sid='30'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The comprehensive assessment procedure included a detailed history using a semi-structured interview, clinical examination, including physical, neurological, psychiatric, and neuropsychological examinations, and routine blood tests.</s><s sid='31'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> A total of 215 subjects fulfilled the inclusion criteria and constituted the baseline population.</s><s sid='32'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Patients were followed annually with the same assessment battery.</s></p></sec><sec id='sec2_2'><title>Ethical Issues</title><p><s sid='33'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The study was approved by the regional Ethics Committee and the Norwegian authorities for collection of medical data.</s><s sid='34'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The patients provided written consent to participate in the study after the study procedures had been explained in detail to the patient and a caregiver, usually the spouse or offspring.</s></p></sec><sec id='sec2_3'><title>Dementia Diagnosis</title><p><s sid='35'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Diagnoses were made after a detailed assessment as previously described [<xref rid='B16' ref-type='bibr'>16</xref>], including the use of standardised clinical assessments of psychiatric symptoms, including hallucinations and depression, parkinsonism and cognitive fluctuations, and MRI and blood tests.</s><s sid='36'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Cerebrospinal fluid was analysed in a subgroup of patients, and most patients with suspected DLB completed a dopamine transporter SPECT scan.</s><s sid='37'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Patients with acute delirium, terminal illness, recently diagnosed with a major somatic illness, previous bipolar disorder or psychotic disorder were excluded.</s></p><p><s sid='38'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Two of the investigators independently applied the diagnostic criteria after baseline and 2 years later.</s><s sid='39'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In cases of disagreement, and in patients fulfilling more than one set of operationalised diagnostic criteria, the final ascertainment was made based on consensus.</s><s sid='40'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In our present study, DLB and PDD were combined into one group (LBD), because these conditions have several clinical and biological similarities [<xref rid='B17' ref-type='bibr'>17</xref>, <xref rid='B18' ref-type='bibr'>18</xref>].</s></p><p><s sid='41'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>To determine apolipoprotein E (APOE) genotypes, genomic DNA was extracted from 200 μl EDTA blood using the QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germany).</s><s sid='42'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The APOE ∊2, ∊3 and ∊4 genotypes, which are determined by the combination of two SNPs (rs7412 and rs429358), were detected using the LightCycler <italic>APOE</italic> Mutation Detection Kit (Roche Diagnostics, Mannheim, Germany).</s><s sid='43'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The assay was used according to the manufacturer's instructions.</s></p></sec><sec id='sec2_4'><title>Assessment of Depression</title><p><s sid='44'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc2>Depression was assessed using the depression subitem of the Neuropsychiatric Inventory (NPId) and the Montgomery-Åsberg Depression Rating Scale (MADRS), and defined as previously described [<xref rid='B15' ref-type='bibr'>15</xref>].</s><s sid='45'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The NPI was specifically designed to assess psychiatric symptoms in subjects with dementia, based on a structured interview of a caregiver [<xref rid='B19' ref-type='bibr'>19</xref>], and the Norwegian version has been validated [<xref rid='B20' ref-type='bibr'>20</xref>].</s><s sid='46'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> It consists of 12 items, including a depression (dysphoria) item (NPId), with a maximum score of 12.</s><s sid='47'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> A cutoff score of ≥1 was used to detect any depression, and a cutoff score of ≥4 was used for clinically relevant depression [<xref rid='B21' ref-type='bibr'>21</xref>].</s></p><p><s sid='48'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>MADRS [<xref rid='B22' ref-type='bibr'>22</xref>] is a clinical interview with 10 items, each scored from 0 to 6, and was completed by an experienced licensed geriatrician or psychiatrist, after a training procedure.</s><s sid='49'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Raters met biannually to ensure similar administration of the instruments.</s><s sid='50'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> A cutoff score of ≥7 was used to detect at least mild depression [<xref rid='B23' ref-type='bibr'>23</xref>], and a cutoff of ≥15 for clinically significant depression [<xref rid='B24' ref-type='bibr'>24</xref>].</s><s sid='51'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> MADRS has been found to provide a good measure of depression relatively independent from dementia severity [<xref rid='B25' ref-type='bibr'>25</xref>].</s><s sid='52'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> A history of clinically relevant (i.e. needing therapy) depression was asked for in the interview.</s><s sid='53'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Depression was assessed at baseline and at a follow-up evaluation 1 year later.</s><s sid='54'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Based on the MADRS cutoff scores, depression status was classified as never depressed, incident depression, persistent depression or recovered.</s><s sid='55'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The same procedure was performed based on the NPId cutoff scores.</s></p></sec><sec id='sec2_5'><title>Assessment of Physical Comorbidity</title><p><s sid='56'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>For assessment of physical comorbidity, we employed the Cumulative Illness Rating Scale (CIRS), which measures the chronic medical illness burden, while taking into account the severity of chronic diseases.</s><s sid='57'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> It was scored by a licensed and experienced geriatrician (S.P.N.) in accordance with the guidelines [<xref rid='B26' ref-type='bibr'>26</xref>].</s></p></sec><sec id='sec2_6'><title>MRI</title><p><s sid='58'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The subjects were scanned at three different sites: the Stavanger University Hospital, the Haugesund Hospital, and the Haraldsplass Deaconess Hospital (Bergen).</s><s sid='59'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A 1.5-T scanner was used in all three centres (Philips Intera in Stavanger and Haugesund, and a 1.5T GE Signa Excite scanner in Bergen).</s><s sid='60'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> MRI was done with the same scanner in each centre during the entire study period, and a common study imaging protocol was used.</s><s sid='61'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In some cases, scans were excluded due to insufficient image quality, not having both FLAIR and T1 images for the patient, or movement artefacts or other artefacts.</s></p></sec><sec id='sec2_7'><title>Volumetric Assessment of WMH</title><sec id='sec3_1'><title>3D T1-Weighted Sequence</title><p><s sid='62'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><italic>Stavanger.</italic> Repetition time (TR)/echo time (TE) 10.0/4.6 ms, flip angle 30.0°, 2-mm slice thickness with 1 mm spacing between the slices (1-mm slices with no gap), number of excitations (NEX) 2, Matrix 256 × 256, field of view (FOV) 26 cm.</s></p><p><s sid='63'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><italic>Haugesund.</italic> TR/TE 20.0/4.6 ms, flip angle 30.0°, 1-mm slice thickness with 1 mm spacing between the slices, NEX 1, Matrix 512 × 512, FOV 26 cm.</s></p><p><s sid='64'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><italic>Bergen.</italic> TR/TE 8.2/3.1 ms, flip angle 7°, 1-mm slice thickness with 1 mm spacing between the slices, inversion time (TI) 500 ms, NEX 1, Matrix 256 × 256, FOV 25.6 cm.</s></p></sec><sec id='sec3_2'><title>FLAIR Sequence</title><p><s sid='65'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><italic>Stavanger.</italic> TR/TE 6,000/100 ms, TI 2,000 ms, 4-mm slice thickness/1-mm gap, NEX 2, Matrix 256 × 256.</s></p><p><s sid='66'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><italic>Haugesund.</italic> TR/TE/TI 6,000/110/2,000 ms, 4-mm slice thickness/1-mm gap, NEX 2, Matrix 512 × 512.</s></p><p><s sid='67'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1><italic>Bergen.</italic> TR/TE 7,927/105.4 ms, flip angle 90°, 4-mm slice thickness/1-mm gap, TI 1,981 ms, NEX 1, Matrix 256 × 256.</s></p></sec><sec id='sec3_3'><title>Processing and Analysis of 3D T1-Weighted Scans and Axial FLAIR Images</title><p><s sid='68'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Image analysis was performed according to a method developed and previously published by Firbank et al. [<xref rid='B27' ref-type='bibr'>27</xref>].</s><s sid='69'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> This method requires sets of 3D T1-weighted scans and axial FLAIR images.</s></p><p><s sid='70'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The non-brain regions were removed from the T1 image, using the segmentation routines in SPM5 (<ext-link ext-link-type='uri' xlink:href='http://www.fil.ion.ucl.ac.uk/spm'>http://www.fil.ion.ucl.ac.uk/spm</ext-link>), and the WMH were segmented on a slice-by-slice basis from the FLAIR image, with the images in native space, using a threshold determined from the histogram of pixel intensities for each image slice.</s></p><p><s sid='71'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>To explore the regional distribution of WMH throughout the brain, a region of interest (ROI) template in standard MNI space was used (Montreal Neurological Institute, <ext-link ext-link-type='uri' xlink:href='http://www.bic.mni.mcgill.ca'>http://www.bic.mni.mcgill.ca</ext-link>).</s><s sid='72'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> This ROI template was transformed from MNI space to the image space (FLAIR) of each subject by use of the normalization routines in SPM5, and the volumes of WMH in each ROI were calculated.</s><s sid='73'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The ROI map was based on the Brodmann template, which is provided as part of MRICro (<ext-link ext-link-type='uri' xlink:href='http://www.psychology.nottingham.ac.uk/staff/crl/lesion.html#brod'>http://www.psychology.nottingham.ac.uk/staff/crl/lesion.html#brod</ext-link>).</s><s sid='74'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Further details can be found in the study by Firbank et al. [<xref rid='B28' ref-type='bibr'>28</xref>].</s></p><p><s sid='75'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Because of the variability in image quality from the different centres participating in this study, we found it difficult to empirically choose a single threshold level that gave us good enough segmentation results in each subject, as deemed by a qualified radiologist (M.K.B.).</s><s sid='76'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A threshold level of 1.2 was chosen, since it gave an overestimation of the lesion load in every subject.</s><s sid='77'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Manual editing was then done to correct for this, by removing excess pixels using FSLView (<ext-link ext-link-type='uri' xlink:href='http://www.fmrib.ox.ac.uk/fsl/index.html'>http://www.fmrib.ox.ac.uk/fsl/index.html</ext-link>).</s></p><p><s sid='78'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>A specialist in internal medicine and geriatrics (H.S.) did the manual editing, blind to clinical data, after training by a consultant neuroradiologist (M.K.B.).</s><s sid='79'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> They both edited the same 10 datasets twice; once at the beginning, to ensure good interrater reliability, and a second time at the end to ensure that similar reliability still persisted and to evaluate intrarater reliability.</s><s sid='80'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The intraclass correlation coefficient was calculated to be 0.998 for interrater reliability and 0.964 for intrarater reliability.</s><s sid='81'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The manually edited scans were then used in the further analysis of volumes of total and regional WMH.</s><s sid='82'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In order to compensate for interindividual differences in total brain volumes, so as to be able to make comparisons between individual patients, we calculated the ratios of volumes of WMH to total brain volumes, which were then used in the statistical analyses.</s></p></sec></sec><sec id='sec2_8'><title>Visual Assessment of WMH</title><p><s sid='83'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>MRIs were also rated visually, using the Scheltens scale [<xref rid='B29' ref-type='bibr'>29</xref>], by an experienced radiologist (O.J.G.) blind to clinical data.</s><s sid='84'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Interrater reliability with another neuroradiologist (M.K.B.) was analysed, based on 12 scans, finding an intraclass correlation coefficient of 0.923.</s></p></sec><sec id='sec2_9'><title>Statistics</title><p><s sid='85'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Baseline comparisons were made using the independent-samples t test, the χ<sup>2</sup> test or Fisher's exact test, as appropriate.</s><s sid='86'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Depression scores for subjects with and without volumetric MRI were compared using the independent-samples t test or the Mann-Whitney U test, as appropriate.</s><s sid='87'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Patients with and without depression were compared using the χ<sup>2</sup> test, the independent-samples t test or the Mann-Whitney U test, as appropriate.</s><s sid='88'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Spearman's rank order correlations between WMH ratios, Scheltens scores and depression measures, including change between baseline and follow-up, were performed.</s><s sid='89'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> WMH ratios and Scheltens scores in the various depression status groups at baseline and follow-up were compared using the Mann-Whitney U test.</s><s sid='90'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Analysis of covariance (ANCOVA) was performed to control for effects of centre affiliation and other potential confounders. p values &lt;0.05 (two-tailed) were considered statistically significant.</s><s sid='91'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Potential predictor variables were included in stepwise multiple logistic regression analyses together with frontal deep WMH ratios or total WMH ratios, using the various definitions of depression as response variable.</s><s sid='92'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For these analyses, the frontal deep and total WMH ratios were multiplied by 100 due to very small absolute values.</s></p><p><s sid='93'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Subjects with missing data for a given analysis were excluded from that specific analysis.</s><s sid='94'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For determination of the normality status of continuous variables, we used the Kolmogorov-Smirnov test.</s><s sid='95'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> All statistical tests were performed using PASW Statistics 18, release 18.0.1.</s></p></sec></sec><sec sec-type='results' id='sec1_3'><title>Results</title><p><s sid='96'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Of the 215 participants included at baseline, 9 were excluded later.</s><s sid='97'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Of these, 5 were rediagnosed as having mild cognitive impairment, 2 withdrew from the study and 2 were excluded due to lack of complete data.</s><s sid='98'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> A total of 190 of the 206 (92%) remaining participants completed the 1-year follow-up examination.</s><s sid='99'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Death was the major reason for dropout, as 10 died during the first year follow-up period.</s><s sid='100'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> The other reasons for not being seen at the 1-year follow-up were patient refusal (n = 5) or caregiver refusal (n = 1).</s></p><p><s sid='101'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>MRI scans of 77 participants were of sufficient quality for volumetric WMH analysis, and 137 scans could be rated semiquantitatively according to the Scheltens scale.</s><s sid='102'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The correlations between the WMH (total and deep frontal) ratios and the Scheltens (total and frontal) scores were highly significant (Spearman's rho 0.838 and 0.839, respectively, p &lt; 0.001).</s></p><p><s sid='103'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Among the patients with scans included in the volumetric analyses (‘completers’), there was a significantly higher proportion of subjects with AD and a lower proportion with DLB/PDD, and they had a somewhat shorter mean disease duration than patients who were not included in the volumetric analyses (‘non-completers’).</s><s sid='104'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Otherwise, there were no significant differences between the 77 completers and the 129 non-completers in demographic and clinical variables at baseline (table <xref rid='T1' ref-type='table'>1</xref>).</s></p><p><s sid='105'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>There were no significant differences between the 137 subjects with scans rated with the Scheltens scale and the rest of the subjects (n = 69) with regard to baseline clinical characteristics (data not shown).</s></p><p><s sid='106'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>At baseline, 33 of the 77 patients included in the volumetric analyses were depressed and 44 were not depressed, using a MADRS cutoff score of ≥7.</s><s sid='107'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There were no significant differences between depressed and non-depressed patients with regard to sex, use of psychoactive medications, MMSE scores, CIRS total scores, and APOE ∊4 at baseline, but the depressed were significantly younger and included significantly more patients with prior depression and patients with non-AD dementia (table <xref rid='T2' ref-type='table'>2</xref>).</s><s sid='108'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> However, the significance of the age difference disappeared after controlling for centre affiliation (data not shown).</s></p><p><s sid='109'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Using a MADRS cutoff score of ≥15, 14 were depressed and 63 not depressed.</s><s sid='110'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The only significant differences regarding the above-mentioned variables were that the depressed significantly more often had also prior depression (9/14 vs. 13/63, p = 0.003), and significantly more often were using antidepressants (8/14 vs. 15/63, p = 0.024).</s></p><p><s sid='111'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>At the 1-year follow-up, there were no significant differences in the proportions of the depressed and non-depressed receiving antidepressants (MADRS cutoff ≥7; 13/24 vs. 13/33, p = 0.403, MADRS cutoff ≥15; 3/5 vs. 23/52, p = 0.651).</s></p><sec id='sec2_10'><title>Baseline Analyses</title><p><s sid='112'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>At baseline, significant positive correlations with MADRS scores were found for both total (Spearman's correlation coefficient 0.274, p = 0.016) and frontal deep WMH ratios (Spearman's correlation coefficient 0.238, p = 0.037), and patients with MADRS scores of ≥7 had significantly higher total and frontal deep WMH ratios than patients with MADRS scores of &lt;7 (p = 0.011 and p = 0.023, respectively).</s><s sid='113'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Similarly, patients with MADRS scores of ≥15 had higher total and frontal deep WMH ratios (p = 0.018 and p = 0.015, respectively) than those with MADRS scores of 14 or lower.</s></p><p><s sid='114'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In contrast, there were no significant correlations between baseline NPId and total and frontal WMH ratios (p = 0.163 and 0.149, respectively).</s><s sid='115'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> However, when using a NPId depression cutoff score of ≥4, the depressed (n = 16/75) had significantly higher total and frontal deep WMH ratios (p = 0.010 and p = 0.019, respectively).</s><s sid='116'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> No significant differences were found using a NPId depression cutoff score of ≥1.</s></p><p><s sid='117'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>When analysing AD and LBD patients separately, a trend towards a significant positive correlation was found between frontal deep WMH ratios and baseline MADRS scores in AD patients (Spearman's correlation coefficient 0.254, p = 0.052), but not in LBD patients (Spearman's correlation coefficient 0.467, p = 0.126).</s><s sid='118'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Total WMH ratios did not differ between AD or LBD patients according to depression (data not shown).</s></p><p><s sid='119'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>No significant associations were found between Scheltens total and frontal scores and the depression measures at baseline, except that patients with a NPId score of ≥4 had significantly higher Scheltens deep frontal scores (p = 0.034) than those with a NPId score of &lt;4.</s></p><p><s sid='120'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>We performed stepwise multiple logistic regression in order to assess the potential confounding effects and relative contributions of variables other than total and frontal deep WMH on the odds of having a MADRS score of ≥7 at baseline.</s></p><p><s sid='121'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Due to high correlation between total and frontal deep WMH (correlation coefficient 0.797, p &lt; 0.001), we performed separate analyses for these variables.</s><s sid='122'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The initial models contained, in addition to the WMH variable, five other independent variables (non-AD vs. AD, age at baseline, sex, CIRS total score and prior depression), all of which have been associated with depression in previous studies [<xref rid='B15' ref-type='bibr'>15</xref>, <xref rid='B30' ref-type='bibr'>30</xref>, <xref rid='B31' ref-type='bibr'>31</xref>, <xref rid='B32' ref-type='bibr'>32</xref>, <xref rid='B33' ref-type='bibr'>33</xref>].</s></p><p><s sid='123'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>The final model concerning frontal deep WMH was statistically significant (Omnibus test of model coefficients p &lt; 0.0005).</s><s sid='124'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Frontal deep WMH, in addition to prior depression and type of dementia, were still significantly associated with a baseline MADRS score of ≥7 (table <xref rid='T3a' ref-type='table'>3a</xref>).</s></p><p><s sid='125'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Similar results emerged for total WMH.</s><s sid='126'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The final model was statistically significant (Omnibus test of model coefficients p &lt; 0.0005), and total WMH were significantly associated with a baseline MADRS score of ≥7 (table <xref rid='T3b' ref-type='table'>3b</xref>).</s></p><p><s sid='127'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Due to the low numbers of patients having clinically significant depression (i.e. MADRS ≥15 or NPId ≥4) at baseline and at follow-up (MADRS n = 5/65 and NPId n = 16/67), only two independent variables could be used in the multiple logistic regression analyses using these cutoffs.</s><s sid='128'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For the same reason, these analyses could be performed only regarding the effect of the independent variables on the risk of being clinically depressed at baseline, but not at follow-up.</s><s sid='129'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Based on the results of previous analyses, as well as bivariate logistic regression analyses (data not shown), prior depression yes/no or AD/non-AD were entered as independent variables in stepwise multiple logistic regression analyses, together with either frontal deep WMH ratios or total WMH ratios.</s></p><p><s sid='130'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Using MADRS scores of &lt;15 versus ≥15 as the response variable, both a higher frontal deep WMH ratio and prior depression were significant predictors of having a MADRS score of ≥15.</s><s sid='131'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Replacing prior depression with AD/non-AD in the analysis, only the frontal deep WMH ratio remained significant.</s><s sid='132'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Similar findings emerged for the total WMH ratio (table <xref rid='T4a' ref-type='table'>4a</xref><xref rid='T4b' ref-type='table'></xref><xref rid='T4c' ref-type='table'></xref>–<xref rid='T4d' ref-type='table'>d</xref>).</s></p><p><s sid='133'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Using NPId scores of &lt;4 versus ≥4 as the response variable, only prior depression was significant when entered with frontal deep WMH ratios into the analysis (the validity of the model fit was uncertain, Pearson χ<sup>2</sup> goodness-of-fit value = 0.000).</s><s sid='134'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> However, only higher frontal deep WMH ratios were significantly associated with NPId scores of ≥4 when entered into the analysis with AD/non-AD.</s><s sid='135'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Replacing frontal deep WMH ratios with total WMH ratios, higher total WMH ratios, but not prior depression or AD/non-AD were significantly associated with a NPId score of ≥4 (table <xref rid='T5a' ref-type='table'>5a</xref><xref rid='T5b' ref-type='table'></xref><xref rid='T5c' ref-type='table'></xref>–<xref rid='T5d' ref-type='table'>d</xref>).</s></p><p><s sid='136'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>All the models having clinically significant depression as response variable were statistically significant, i.e. Omnibus test of model coefficients p &lt; 0.05.</s></p></sec><sec id='sec2_11'><title>Course of Depression</title><p><s sid='137'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>The median change in MADRS scores was +1.0.</s><s sid='138'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Of the 206 subjects, 47% had a MADRS score of ≥7 at the 1-year follow-up, and 12% had a MADRS score of ≥15.</s><s sid='139'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Using a MADRS cutoff score for depression of ≥15, 20 out of 35 (57%) recovered and 5% had incident depression.</s><s sid='140'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Baseline total and frontal deep WMH were not correlated with MADRS (p = 0.459 and p = 0.537, respectively) or NPId (p = 0.697 and p = 0.329, respectively) scores at the 1-year follow-up.</s></p><p><s sid='141'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Using cutoff scores for depression of ≥7 and ≥1, respectively, for MADRS and NPId, there were no significant differences in WMH ratios when comparing patients with favourable (i.e. never depressed or remission) and unfavourable (i.e. new depression or persistence) courses of depression, in remission versus persistent depression, or between patients who had never had depression versus those with persistent depression.</s><s sid='142'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Finally, changes between baseline and follow-up MADRS and NPId scores were not significantly correlated with WMH ratios at baseline.</s></p><p><s sid='143'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>However, patients with MADRS scores of ≥15 at follow-up had significantly higher baseline volumes of both total and frontal deep WMH (p = 0.012 and p =0.006, respectively) than those with a MADRS score of ≤14.</s><s sid='144'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Furthermore, patients with an unfavourable course according to MADRS scores had significantly higher volumes of both total and frontal deep WMH (p = 0.012 and p = 0.006, respectively).</s><s sid='145'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the NPId, this was the case only for frontal deep WMH (p = 0.047).</s><s sid='146'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> There were no significant differences between patients with remission compared to those with persistent depression with respect to WMH volumes.</s><s sid='147'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> When comparing patients with no depression and patients with persistent depression, the only significant difference was that patients with persistent depression based on the NPId had significantly higher volumes of frontal deep WMH (p = 0.031).</s><s sid='148'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There were no other associations using the NPId ≥4 cutoff score.</s></p><p><s sid='149'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>No significant associations were found between Scheltens total and frontal scores and the course of depression variables.</s></p></sec></sec><sec sec-type='discussion' id='sec1_4'><title>Discussion</title><sec id='sec2_12'><title>Main Findings</title><p><s sid='150'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>The main finding of this study was that the volume ratios of WMH were positively and independently correlated with depression at baseline.</s><s sid='151'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Furthermore, the results suggest that having higher WMH volume ratios at baseline may be associated with a higher risk of having depression or an unfavourable course of depression at the 1-year follow-up.</s></p></sec><sec id='sec2_13'><title>Interpretation</title><p><s sid='152'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The results of our study are consistent with some previous studies [<xref rid='B3' ref-type='bibr'>3</xref>, <xref rid='B9' ref-type='bibr'>9</xref>], and similar findings have been reported also in non-demented elderly [<xref rid='B7' ref-type='bibr'>7</xref>, <xref rid='B34' ref-type='bibr'>34</xref>].</s><s sid='153'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, other studies did not find such a relationship, although this was based on a combination of psychiatric symptoms rather than a specific measure of depression [<xref rid='B10' ref-type='bibr'>10</xref>].</s><s sid='154'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Thus, our findings support the hypothesis that WMH predispose elderly individuals, with or without dementia, to developing depression.</s><s sid='155'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> One possible mechanism is disruption of fibre tracts connecting cortical and subcortical structures involved in the regulation of mood [<xref rid='B1' ref-type='bibr'>1</xref>].</s></p><p><s sid='156'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1>However, our hypothesis that the prognosis of depressive symptoms in persons with mild dementia is related to the volume of WMH, and frontal deep WMH in particular, was less robustly supported.</s><s sid='157'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> One partial explanation could be the rather low total number of patients, and consequently a low number of patients having clinically significant depression in our study, resulting in limited possibilities for multivariable statistical analysis.</s><s sid='158'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> Moreover, cerebrovascular disease is a chronic condition that may exert its major influence early in the course of dementia, and other factors, intrinsic and extrinsic, could be more important determinants of the course of depression at later stages.</s><s sid='159'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> These factors may include neurotransmitter changes [<xref rid='B35' ref-type='bibr'>35</xref>], inflammation [<xref rid='B36' ref-type='bibr'>36</xref>], physical comorbidity [<xref rid='B37' ref-type='bibr'>37</xref>], environmental factors [<xref rid='B38' ref-type='bibr'>38</xref>], treatment [<xref rid='B39' ref-type='bibr'>39</xref>], and disability [<xref rid='B6' ref-type='bibr'>6</xref>].</s><s sid='160'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Of note, we recently found that worsening of depressive symptoms was associated with a more rapid cognitive decline, suggesting that the degenerative changes at this stage of the disease are the key determinants of depression in people with early AD and LBD [<xref rid='B11' ref-type='bibr'>11</xref>].</s><s sid='161'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Finally, the less-than-robust support for our hypothesis might be related to longitudinal changes in depression in elderly patients with dementia [<xref rid='B40' ref-type='bibr'>40</xref>].</s></p><p><s sid='162'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>The observed trend towards a differential relationship between WMH and depression in AD versus LBD is most likely due to differences in statistical power, due to the small number of LBD patients.</s></p><p><s sid='163'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>We did, somewhat surprisingly, find almost no correlations or associations between Scheltens scores and depression variables.</s><s sid='164'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> This is in contrast to findings in a previous study [<xref rid='B3' ref-type='bibr'>3</xref>].</s><s sid='165'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Notably, this previous study included persons with more advanced dementia (mean MMSE scores of 13.6–18.2) than our study.</s><s sid='166'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> This discrepancy could also be due to visual scoring methods, e.g. the Scheltens scale, being less sensitive than volumetric methods [<xref rid='B41' ref-type='bibr'>41</xref>], despite the high correlations between the results of these methods.</s><s sid='167'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Unlike volumetric methods, visual rating scales, such as the Scheltens scale, display ceiling effects and poor discrimination of absolute lesion volumes [<xref rid='B41' ref-type='bibr'>41</xref>].</s></p></sec><sec id='sec2_14'><title>Strengths and Limitations</title><p><s sid='168'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Strengths of this study include the longitudinal design and the quantitative method for measuring WMH.</s><s sid='169'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Limitations include the relatively low number of cases, which limits the statistical power of the study, particularly for the LBD group.</s><s sid='170'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Moreover, our sample was recruited from secondary care outpatient clinics, and may therefore not be representative of the general population with mild dementia.</s><s sid='171'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Thus, the generalisability of our findings may be limited.</s><s sid='172'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The change in depression was relatively small, probably due to the relatively short study period, which also limits the statistical power to detect associations with the longitudinal course of depression.</s><s sid='173'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> A longer observation period might have increased the likelihood of finding an association between WMH and the course of depression.</s><s sid='174'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Another possible limitation is that depression was assessed using scale scores rather than using a structured psychiatric interview and diagnoses based on standardised criteria.</s><s sid='175'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The diagnosis in the majority of cases was clinical, and thus misdiagnosis cannot be excluded.</s><s sid='176'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> However, standardised and validated scales were used, also to support the diagnosis of DLB, where the clinical diagnosis was confirmed in all 7 patients who came to autopsy [Dag Aarsland, pers. commun., 2011].</s><s sid='177'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> We combined patients with DLB and PDD into one LBD group.</s><s sid='178'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Although the two syndromes differ in the temporal sequence of symptoms and in the relative severity of cortical amyloid pathology, we consider them sufficiently similar to be combined in a study of WMH.</s><s sid='179'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Furthermore, patients were followed longitudinally, which also is likely to increase diagnostic accuracy.</s><s sid='180'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> We used two different measures of depression, one observer-based (MADRS) and one carer-based (NPId).</s><s sid='181'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Stronger associations with WMH were found for MADRS, suggesting that this is a more sensitive measure of depression in mild dementia.</s><s sid='182'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Finally, since this was a naturalistic study, we could not control for possible treatment changes during the study period, which might influence the course of depression and thus mask a possible relationship between WMH and the course of depression.</s></p></sec><sec id='sec2_15'><title>Clinical Implications and Future Research</title><p><s sid='183'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>One implication of our findings is that prevention or reduction of WMH, if possible, could lessen the burden of depression and depressive symptoms in persons with mild dementia.</s><s sid='184'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> This might be accomplished by means of therapies directed against established risk factors for stroke and WMH, such as hypertension and diabetes [<xref rid='B42' ref-type='bibr'>42</xref>].</s><s sid='185'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Such preventive measures, which would at least have several other positive health effects, should probably be initiated in midlife [<xref rid='B43' ref-type='bibr'>43</xref>].</s><s sid='186'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> The importance of such potentially preventive strategies is increased in light of recent studies suggesting that antidepressants may not be effective for depressed patients with dementia [<xref rid='B44' ref-type='bibr'>44</xref>].</s></p><p><s sid='187'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1>Further studies of the mechanisms that determine the course of depression in people with mild dementia are clearly called for.</s><s sid='188'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> These studies should be sufficiently powered and of longer duration, as well as including patients with non-AD dementias such as LBD and vascular dementia.</s></p></sec></sec><sec id='sec1_5'><title>Disclosure Statement</title><p>None of the authors has any conflicts of interest related to the current article.</p></sec></body><back><ack><title>Acknowledgement</title><p>This study was supported financially by Helse Stavanger HF and by grant 911694 from the Western Norway Regional Health Authority.</p></ack><ref-list><title>References</title><ref id='B1'><label>1</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Herrmann</surname><given-names>LL</given-names></name><name><surname>Le Masurier</surname><given-names>M</given-names></name><name><surname>Ebmeier</surname><given-names>KP</given-names></name></person-group><article-title>White matter hyperintensities in late life depression: a systematic review</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2008</year><volume>79</volume><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type='pmid'>17717021</pub-id></element-citation></ref><ref id='B2'><label>2</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>van Swieten</surname><given-names>JC</given-names></name><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Claus</surname><given-names>JJ</given-names></name><name><surname>van den Hout</surname><given-names>JH</given-names></name><name><surname>van Harskamp</surname><given-names>F</given-names></name><name><surname>Tanghe</surname><given-names>HL</given-names></name><name><surname>de Jong</surname><given-names>PT</given-names></name><name><surname>van Gijn</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study</article-title><source>Neurology</source><year>1994</year><volume>44</volume><fpage>1246</fpage><lpage>1252</lpage><pub-id pub-id-type='pmid'>8035924</pub-id></element-citation></ref><ref id='B3'><label>3</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Barber</surname><given-names>R</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Gholkar</surname><given-names>A</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>McKeith</surname><given-names>I</given-names></name><name><surname>Ince</surname><given-names>P</given-names></name><name><surname>Perry</surname><given-names>R</given-names></name><name><surname>O'Brien</surname><given-names>J</given-names></name></person-group><article-title>White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1999</year><volume>67</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type='pmid'>10369824</pub-id></element-citation></ref><ref id='B4'><label>4</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>de Kersaint-Gilly</surname><given-names>A</given-names></name><name><surname>Besancon</surname><given-names>V</given-names></name><name><surname>Levy</surname><given-names>C</given-names></name><name><surname>Auffray</surname><given-names>E</given-names></name><name><surname>Brunnereau</surname><given-names>L</given-names></name><name><surname>Alperovitch</surname><given-names>A</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name></person-group><article-title>Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort</article-title><source>Neurology</source><year>2001</year><volume>56</volume><fpage>921</fpage><lpage>926</lpage><pub-id pub-id-type='pmid'>11294930</pub-id></element-citation></ref><ref id='B5'><label>5</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Wakefield</surname><given-names>DB</given-names></name><name><surname>Moscufo</surname><given-names>N</given-names></name><name><surname>Guttmann</surname><given-names>CR</given-names></name><name><surname>Kuchel</surname><given-names>GA</given-names></name><name><surname>Kaplan</surname><given-names>RF</given-names></name><name><surname>Pearlson</surname><given-names>G</given-names></name><name><surname>Wolfson</surname><given-names>L</given-names></name></person-group><article-title>White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults</article-title><source>J Am Geriatr Soc</source><year>2010</year><volume>58</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type='pmid'>20374403</pub-id></element-citation></ref><ref id='B6'><label>6</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Teodorczuk</surname><given-names>A</given-names></name><name><surname>Firbank</surname><given-names>MJ</given-names></name><name><surname>Pantoni</surname><given-names>L</given-names></name><name><surname>Poggesi</surname><given-names>A</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Wallin</surname><given-names>A</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Waldemar</surname><given-names>G</given-names></name><name><surname>Schrotter</surname><given-names>G</given-names></name><name><surname>Ferro</surname><given-names>JM</given-names></name><name><surname>Chabriat</surname><given-names>H</given-names></name><name><surname>Bazner</surname><given-names>H</given-names></name><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Inzitari</surname><given-names>D</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name></person-group><article-title>Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study</article-title><source>Psychol Med</source><year>2010</year><volume>40</volume><fpage>603</fpage><lpage>610</lpage><pub-id pub-id-type='pmid'>19671212</pub-id></element-citation></ref><ref id='B7'><label>7</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Godin</surname><given-names>O</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Maillard</surname><given-names>P</given-names></name><name><surname>Delcroix</surname><given-names>N</given-names></name><name><surname>Mazoyer</surname><given-names>B</given-names></name><name><surname>Crivello</surname><given-names>F</given-names></name><name><surname>Alperovitch</surname><given-names>A</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name></person-group><article-title>White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study</article-title><source>Biol Psychiatry</source><year>2008</year><volume>63</volume><fpage>663</fpage><lpage>669</lpage><pub-id pub-id-type='pmid'>17977521</pub-id></element-citation></ref><ref id='B8'><label>8</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>O'Brien</surname><given-names>J</given-names></name><name><surname>Ames</surname><given-names>D</given-names></name><name><surname>Chiu</surname><given-names>E</given-names></name><name><surname>Schweitzer</surname><given-names>I</given-names></name><name><surname>Desmond</surname><given-names>P</given-names></name><name><surname>Tress</surname><given-names>B</given-names></name></person-group><article-title>Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow-up study</article-title><source>BMJ</source><year>1998</year><volume>317</volume><fpage>982</fpage><lpage>984</lpage><pub-id pub-id-type='pmid'>9765166</pub-id></element-citation></ref><ref id='B9'><label>9</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>O'Brien</surname><given-names>J</given-names></name><name><surname>Perry</surname><given-names>R</given-names></name><name><surname>Barber</surname><given-names>R</given-names></name><name><surname>Gholkar</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name></person-group><article-title>The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms</article-title><source>Ann N Y Acad Sci</source><year>2000</year><volume>903</volume><fpage>482</fpage><lpage>489</lpage><pub-id pub-id-type='pmid'>10818542</pub-id></element-citation></ref><ref id='B10'><label>10</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Modrego</surname><given-names>PJ</given-names></name><name><surname>Rios</surname><given-names>C</given-names></name><name><surname>Perez Trullen</surname><given-names>JM</given-names></name><name><surname>Errea</surname><given-names>JM</given-names></name><name><surname>Garcia-Gomara</surname><given-names>MJ</given-names></name><name><surname>Sanchez</surname><given-names>S</given-names></name></person-group><article-title>The cerebrovascular pathology in Alzheimer's disease and its influence on clinical variables</article-title><source>Am J Alzheimers Dis Other Demen</source><year>2008</year><volume>23</volume><fpage>91</fpage><lpage>96</lpage><pub-id pub-id-type='pmid'>18276961</pub-id></element-citation></ref><ref id='B11'><label>11</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Fritze</surname><given-names>F</given-names></name><name><surname>Ehrt</surname><given-names>U</given-names></name><name><surname>Hortobagyi</surname><given-names>T</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name></person-group><article-title>Depressive symptoms in Alzheimer's disease and Lewy body dementia: a one-year follow-up study</article-title><source>Dement Geriatr Cogn Disord</source><year>2011</year><volume>32</volume><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type='pmid'>21986003</pub-id></element-citation></ref><ref id='B12'><label>12</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Krishnan</surname><given-names>KR</given-names></name><name><surname>Delong</surname><given-names>M</given-names></name><name><surname>Kraemer</surname><given-names>H</given-names></name><name><surname>Carney</surname><given-names>R</given-names></name><name><surname>Spiegel</surname><given-names>D</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>McDonald</surname><given-names>W</given-names></name><name><surname>Dew</surname><given-names>M</given-names></name><name><surname>Alexopoulos</surname><given-names>G</given-names></name><name><surname>Buckwalter</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>PD</given-names></name><name><surname>Evans</surname><given-names>D</given-names></name><name><surname>Kaufmann</surname><given-names>PG</given-names></name><name><surname>Olin</surname><given-names>J</given-names></name><name><surname>Otey</surname><given-names>E</given-names></name><name><surname>Wainscott</surname><given-names>C</given-names></name></person-group><article-title>Comorbidity of depression with other medical diseases in the elderly</article-title><source>Biol Psychiatry</source><year>2002</year><volume>52</volume><fpage>559</fpage><lpage>588</lpage><pub-id pub-id-type='pmid'>12361669</pub-id></element-citation></ref><ref id='B13'><label>13</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Starkstein</surname><given-names>SE</given-names></name><name><surname>Jorge</surname><given-names>R</given-names></name><name><surname>Mizrahi</surname><given-names>R</given-names></name><name><surname>Robinson</surname><given-names>RG</given-names></name></person-group><article-title>The construct of minor and major depression in Alzheimer's disease</article-title><source>Am J Psychiatry</source><year>2005</year><volume>162</volume><fpage>2086</fpage><lpage>2093</lpage><pub-id pub-id-type='pmid'>16263848</pub-id></element-citation></ref><ref id='B14'><label>14</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Hurt</surname><given-names>C</given-names></name><name><surname>Bhattacharyya</surname><given-names>S</given-names></name><name><surname>Burns</surname><given-names>A</given-names></name><name><surname>Camus</surname><given-names>V</given-names></name><name><surname>Liperoti</surname><given-names>R</given-names></name><name><surname>Marriott</surname><given-names>A</given-names></name><name><surname>Nobili</surname><given-names>F</given-names></name><name><surname>Robert</surname><given-names>P</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Vellas</surname><given-names>B</given-names></name><name><surname>Verhey</surname><given-names>F</given-names></name><name><surname>Byrne</surname><given-names>EJ</given-names></name></person-group><article-title>Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia</article-title><source>Dement Geriatr Cogn Disord</source><year>2008</year><volume>26</volume><fpage>138</fpage><lpage>146</lpage><pub-id pub-id-type='pmid'>18679028</pub-id></element-citation></ref><ref id='B15'><label>15</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Fritze</surname><given-names>F</given-names></name><name><surname>Ehrt</surname><given-names>U</given-names></name><name><surname>Sonnesyn</surname><given-names>H</given-names></name><name><surname>Kurz</surname><given-names>M</given-names></name><name><surname>Hortobagyi</surname><given-names>T</given-names></name><name><surname>Nore</surname><given-names>SP</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name></person-group><article-title>Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features</article-title><source>Int J Geriatr Psychiatry</source><year>2011</year><volume>26</volume><fpage>1054</fpage><lpage>1061</lpage><pub-id pub-id-type='pmid'>21905099</pub-id></element-citation></ref><ref id='B16'><label>16</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Rongve</surname><given-names>A</given-names></name><name><surname>Nore</surname><given-names>SP</given-names></name><name><surname>Skogseth</surname><given-names>R</given-names></name><name><surname>Skulstad</surname><given-names>S</given-names></name><name><surname>Ehrt</surname><given-names>U</given-names></name><name><surname>Hoprekstad</surname><given-names>D</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name></person-group><article-title>Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria</article-title><source>Dement Geriatr Cogn Disord</source><year>2008</year><volume>26</volume><fpage>445</fpage><lpage>452</lpage><pub-id pub-id-type='pmid'>18974647</pub-id></element-citation></ref><ref id='B17'><label>17</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Ballard</surname><given-names>CG</given-names></name><name><surname>Halliday</surname><given-names>G</given-names></name></person-group><article-title>Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?</article-title><source>J Geriatr Psychiatry Neurol</source><year>2004</year><volume>17</volume><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type='pmid'>15312277</pub-id></element-citation></ref><ref id='B18'><label>18</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKeith</surname><given-names>IG</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>Emre</surname><given-names>M</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name><name><surname>Feldman</surname><given-names>H</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Duda</surname><given-names>JE</given-names></name><name><surname>Lippa</surname><given-names>C</given-names></name><name><surname>Perry</surname><given-names>EK</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Ballard</surname><given-names>CG</given-names></name><name><surname>Boeve</surname><given-names>B</given-names></name><name><surname>Burn</surname><given-names>DJ</given-names></name><name><surname>Costa</surname><given-names>D</given-names></name><name><surname>Del Ser</surname><given-names>T</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Gauthier</surname><given-names>S</given-names></name><name><surname>Goetz</surname><given-names>CG</given-names></name><name><surname>Gomez-Tortosa</surname><given-names>E</given-names></name><name><surname>Halliday</surname><given-names>G</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Iwatsubo</surname><given-names>T</given-names></name><name><surname>Kalaria</surname><given-names>RN</given-names></name><name><surname>Kaufer</surname><given-names>D</given-names></name><name><surname>Kenny</surname><given-names>RA</given-names></name><name><surname>Korczyn</surname><given-names>A</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>VM</given-names></name><name><surname>Lees</surname><given-names>A</given-names></name><name><surname>Litvan</surname><given-names>I</given-names></name><name><surname>Londos</surname><given-names>E</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Minoshima</surname><given-names>S</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Molina</surname><given-names>JA</given-names></name><name><surname>Mukaetova-Ladinska</surname><given-names>EB</given-names></name><name><surname>Pasquier</surname><given-names>F</given-names></name><name><surname>Perry</surname><given-names>RH</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name></person-group><article-title>Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1863</fpage><lpage>1872</lpage><pub-id pub-id-type='pmid'>16237129</pub-id></element-citation></ref><ref id='B19'><label>19</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Mega</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>K</given-names></name><name><surname>Rosenberg-Thompson</surname><given-names>S</given-names></name><name><surname>Carusi</surname><given-names>DA</given-names></name><name><surname>Gornbein</surname><given-names>J</given-names></name></person-group><article-title>The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia</article-title><source>Neurology</source><year>1994</year><volume>44</volume><fpage>2308</fpage><lpage>2314</lpage><pub-id pub-id-type='pmid'>7991117</pub-id></element-citation></ref><ref id='B20'><label>20</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Selbaek</surname><given-names>G</given-names></name><name><surname>Kirkevold</surname><given-names>O</given-names></name><name><surname>Sommer</surname><given-names>OH</given-names></name><name><surname>Engedal</surname><given-names>K</given-names></name></person-group><article-title>The reliability and validity of the Norwegian version of the Neuropsychiatric Inventory, nursing home version (NPI-NH)</article-title><source>Int Psychogeriatr</source><year>2008</year><volume>20</volume><fpage>375</fpage><lpage>382</lpage><pub-id pub-id-type='pmid'>17559707</pub-id></element-citation></ref><ref id='B21'><label>21</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Caputo</surname><given-names>M</given-names></name><name><surname>Monastero</surname><given-names>R</given-names></name><name><surname>Mariani</surname><given-names>E</given-names></name><name><surname>Santucci</surname><given-names>A</given-names></name><name><surname>Mangialasche</surname><given-names>F</given-names></name><name><surname>Camarda</surname><given-names>R</given-names></name><name><surname>Senin</surname><given-names>U</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name></person-group><article-title>Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types</article-title><source>Acta Psychiatr Scand</source><year>2008</year><volume>117</volume><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type='pmid'>18363771</pub-id></element-citation></ref><ref id='B22'><label>22</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>Asberg</surname><given-names>M</given-names></name></person-group><article-title>A new depression scale designed to be sensitive to change</article-title><source>Br J Psychiatry</source><year>1979</year><volume>134</volume><fpage>382</fpage><lpage>389</lpage><pub-id pub-id-type='pmid'>444788</pub-id></element-citation></ref><ref id='B23'><label>23</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Snaith</surname><given-names>RP</given-names></name><name><surname>Harrop</surname><given-names>FM</given-names></name><name><surname>Newby</surname><given-names>DA</given-names></name><name><surname>Teale</surname><given-names>C</given-names></name></person-group><article-title>Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales</article-title><source>Br J Psychiatry</source><year>1986</year><volume>148</volume><fpage>599</fpage><lpage>601</lpage><pub-id pub-id-type='pmid'>3779233</pub-id></element-citation></ref><ref id='B24'><label>24</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Leontjevas</surname><given-names>R</given-names></name><name><surname>van Hooren</surname><given-names>S</given-names></name><name><surname>Mulders</surname><given-names>A</given-names></name></person-group><article-title>The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early-onset dementia</article-title><source>Am J Geriatr Psychiatry</source><year>2009</year><volume>17</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type='pmid'>19092312</pub-id></element-citation></ref><ref id='B25'><label>25</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Muller-Thomsen</surname><given-names>T</given-names></name><name><surname>Arlt</surname><given-names>S</given-names></name><name><surname>Mann</surname><given-names>U</given-names></name><name><surname>Mass</surname><given-names>R</given-names></name><name><surname>Ganzer</surname><given-names>S</given-names></name></person-group><article-title>Detecting depression in Alzheimer's disease: evaluation of four different scales</article-title><source>Arch Clin Neuropsychol</source><year>2005</year><volume>20</volume><fpage>271</fpage><lpage>276</lpage><pub-id pub-id-type='pmid'>15708735</pub-id></element-citation></ref><ref id='B26'><label>26</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Conwell</surname><given-names>Y</given-names></name><name><surname>Forbes</surname><given-names>NT</given-names></name><name><surname>Cox</surname><given-names>C</given-names></name><name><surname>Caine</surname><given-names>ED</given-names></name></person-group><article-title>Validation of a measure of physical illness burden at autopsy: The Cumulative Illness Rating Scale</article-title><source>J Am Geriatr Soc</source><year>1993</year><volume>41</volume><fpage>38</fpage><lpage>41</lpage><pub-id pub-id-type='pmid'>8418120</pub-id></element-citation></ref><ref id='B27'><label>27</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Firbank</surname><given-names>MJ</given-names></name><name><surname>Lloyd</surname><given-names>AJ</given-names></name><name><surname>Ferrier</surname><given-names>N</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name></person-group><article-title>A volumetric study of MRI signal hyperintensities in late-life depression</article-title><source>Am J Geriatr Psychiatry</source><year>2004</year><volume>12</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type='pmid'>15545328</pub-id></element-citation></ref><ref id='B28'><label>28</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Firbank</surname><given-names>MJ</given-names></name><name><surname>Minett</surname><given-names>T</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name></person-group><article-title>Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects</article-title><source>Neurology</source><year>2003</year><volume>61</volume><fpage>950</fpage><lpage>954</lpage><pub-id pub-id-type='pmid'>14557566</pub-id></element-citation></ref><ref id='B29'><label>29</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Barkhof</surname><given-names>F</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Pruvo</surname><given-names>JP</given-names></name><name><surname>Nauta</surname><given-names>JJ</given-names></name><name><surname>Vermersch</surname><given-names>P</given-names></name><name><surname>Steinling</surname><given-names>M</given-names></name><name><surname>Valk</surname><given-names>J</given-names></name></person-group><article-title>A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging</article-title><source>J Neurol Sci</source><year>1993</year><volume>114</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type='pmid'>8433101</pub-id></element-citation></ref><ref id='B30'><label>30</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Cole</surname><given-names>MG</given-names></name><name><surname>Dendukuri</surname><given-names>N</given-names></name></person-group><article-title>Risk factors for depression among elderly community subjects: a systematic review and meta-analysis</article-title><source>Am J Psychiatry</source><year>2003</year><volume>160</volume><fpage>1147</fpage><lpage>1156</lpage><pub-id pub-id-type='pmid'>12777274</pub-id></element-citation></ref><ref id='B31'><label>31</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Solhaug</surname><given-names>HI</given-names></name><name><surname>Romuld</surname><given-names>EB</given-names></name><name><surname>Romild</surname><given-names>U</given-names></name><name><surname>Stordal</surname><given-names>E</given-names></name></person-group><article-title>Increased prevalence of depression in cohorts of the elderly: an 11-year follow-up in the general population – the Hunt Study</article-title><source>Int Psychogeriatr</source><year>2012</year><volume>24</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type='pmid'>21767455</pub-id></element-citation></ref><ref id='B32'><label>32</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Cohen</surname><given-names>LS</given-names></name></person-group><article-title>Gender-specific considerations in the treatment of mood disorders in women across the life cycle</article-title><source>J Clin Psychiatry</source><year>2003</year><volume>64</volume><issue>suppl 15</issue><fpage>18</fpage><lpage>29</lpage><pub-id pub-id-type='pmid'>14658987</pub-id></element-citation></ref><ref id='B33'><label>33</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Chang-Quan</surname><given-names>H</given-names></name><name><surname>Xue-Mei</surname><given-names>Z</given-names></name><name><surname>Bi-Rong</surname><given-names>D</given-names></name><name><surname>Zhen-Chan</surname><given-names>L</given-names></name><name><surname>Ji-Rong</surname><given-names>Y</given-names></name><name><surname>Qing-Xiu</surname><given-names>L</given-names></name></person-group><article-title>Health status and risk for depression among the elderly: a meta-analysis of published literature</article-title><source>Age Ageing</source><year>2010</year><volume>39</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type='pmid'>19903775</pub-id></element-citation></ref><ref id='B34'><label>34</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Teodorczuk</surname><given-names>A</given-names></name><name><surname>Firbank</surname><given-names>MJ</given-names></name><name><surname>Pantoni</surname><given-names>L</given-names></name><name><surname>Poggesi</surname><given-names>A</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Wallin</surname><given-names>A</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Waldemar</surname><given-names>G</given-names></name><name><surname>Schrotter</surname><given-names>G</given-names></name><name><surname>Ferro</surname><given-names>JM</given-names></name><name><surname>Chabriat</surname><given-names>H</given-names></name><name><surname>Bazner</surname><given-names>H</given-names></name><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Inzitari</surname><given-names>D</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name></person-group><article-title>Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study</article-title><source>Psychol Med</source><year>2009</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type='pmid'>19335938</pub-id></element-citation></ref><ref id='B35'><label>35</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Korczyn</surname><given-names>AD</given-names></name><name><surname>Halperin</surname><given-names>I</given-names></name></person-group><article-title>Depression and dementia</article-title><source>J Neurol Sci</source><year>2009</year><volume>283</volume><fpage>139</fpage><lpage>142</lpage><pub-id pub-id-type='pmid'>19345960</pub-id></element-citation></ref><ref id='B36'><label>36</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Leonard</surname><given-names>BE</given-names></name></person-group><article-title>Inflammation, depression and dementia: are they connected?</article-title><source>Neurochem Res</source><year>2007</year><volume>32</volume><fpage>1749</fpage><lpage>1756</lpage><pub-id pub-id-type='pmid'>17705097</pub-id></element-citation></ref><ref id='B37'><label>37</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Alexopoulos</surname><given-names>GS</given-names></name></person-group><article-title>Depression in the elderly</article-title><source>Lancet</source><year>2005</year><volume>365</volume><fpage>1961</fpage><lpage>1970</lpage><pub-id pub-id-type='pmid'>15936426</pub-id></element-citation></ref><ref id='B38'><label>38</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Schoevers</surname><given-names>RA</given-names></name><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>Geerlings</surname><given-names>MI</given-names></name><name><surname>Jonker</surname><given-names>C</given-names></name><name><surname>Van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>Risk factors for depression in later life; results of a prospective community based study (AMSTEL)</article-title><source>J Affect Disord</source><year>2000</year><volume>59</volume><fpage>127</fpage><lpage>137</lpage><pub-id pub-id-type='pmid'>10837881</pub-id></element-citation></ref><ref id='B39'><label>39</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Thompson</surname><given-names>S</given-names></name><name><surname>Herrmann</surname><given-names>N</given-names></name><name><surname>Rapoport</surname><given-names>MJ</given-names></name><name><surname>Lanctot</surname><given-names>KL</given-names></name></person-group><article-title>Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis</article-title><source>Can J Psychiatry</source><year>2007</year><volume>52</volume><fpage>248</fpage><lpage>255</lpage><pub-id pub-id-type='pmid'>17500306</pub-id></element-citation></ref><ref id='B40'><label>40</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Wetzels</surname><given-names>R</given-names></name><name><surname>Zuidema</surname><given-names>S</given-names></name><name><surname>Jansen</surname><given-names>I</given-names></name><name><surname>Verhey</surname><given-names>F</given-names></name><name><surname>Koopmans</surname><given-names>R</given-names></name></person-group><article-title>Course of neuropsychiatric symptoms in residents with dementia in long-term care institutions: a systematic review</article-title><source>Int Psychogeriatr</source><year>2010</year><volume>22</volume><fpage>1040</fpage><lpage>1053</lpage><pub-id pub-id-type='pmid'>20678299</pub-id></element-citation></ref><ref id='B41'><label>41</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>van Straaten</surname><given-names>EC</given-names></name><name><surname>Fazekas</surname><given-names>F</given-names></name><name><surname>Rostrup</surname><given-names>E</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Pantoni</surname><given-names>L</given-names></name><name><surname>Inzitari</surname><given-names>D</given-names></name><name><surname>Waldemar</surname><given-names>G</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Mantyla</surname><given-names>R</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Barkhof</surname><given-names>F</given-names></name></person-group><article-title>Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study</article-title><source>Stroke</source><year>2006</year><volume>37</volume><fpage>836</fpage><lpage>840</lpage><pub-id pub-id-type='pmid'>16439704</pub-id></element-citation></ref><ref id='B42'><label>42</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ovbiagele</surname><given-names>B</given-names></name><name><surname>Saver</surname><given-names>JL</given-names></name></person-group><article-title>Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications</article-title><source>Cerebrovasc Dis</source><year>2006</year><volume>22</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type='pmid'>16685119</pub-id></element-citation></ref><ref id='B43'><label>43</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>de Toledo Ferraz Alves</surname><given-names>TC</given-names></name><name><surname>Ferreira</surname><given-names>LK</given-names></name><name><surname>Busatto</surname><given-names>GF</given-names></name></person-group><article-title>Vascular diseases and old age mental disorders: an update of neuroimaging findings</article-title><source>Curr Opin Psychiatry</source><year>2010</year><volume>23</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type='pmid'>20733494</pub-id></element-citation></ref><ref id='B44'><label>44</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Hellier</surname><given-names>J</given-names></name><name><surname>Dewey</surname><given-names>M</given-names></name><name><surname>Romeo</surname><given-names>R</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>Baldwin</surname><given-names>R</given-names></name><name><surname>Bentham</surname><given-names>P</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Holmes</surname><given-names>C</given-names></name><name><surname>Katona</surname><given-names>C</given-names></name><name><surname>Knapp</surname><given-names>M</given-names></name><name><surname>Lawton</surname><given-names>C</given-names></name><name><surname>Lindesay</surname><given-names>J</given-names></name><name><surname>Livingston</surname><given-names>G</given-names></name><name><surname>McCrae</surname><given-names>N</given-names></name><name><surname>Moniz-Cook</surname><given-names>E</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Nurock</surname><given-names>S</given-names></name><name><surname>Orrell</surname><given-names>M</given-names></name><name><surname>O'Brien</surname><given-names>J</given-names></name><name><surname>Poppe</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Walwyn</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>K</given-names></name><name><surname>Burns</surname><given-names>A</given-names></name></person-group><article-title>Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial</article-title><source>Lancet</source><year>2011</year><volume>378</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type='pmid'>21764118</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap orientation='portrait' id='T1' position='float'><label>Table 1</label><caption><p>Baseline clinical characteristics of subjects who participated in the volumetric MRI study (completers) and those who did not participate (non-completers)</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>Non-completers (n = 129)</th><th colspan='1' rowspan='1' align='left'>Completers (n = 77)</th><th colspan='1' rowspan='1' align='left'>p value</th><th colspan='1' rowspan='1' align='left'>Participants missing data (n = 206)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Age</td><td colspan='1' rowspan='1' char='.' align='char'>77.0 (71–82)</td><td colspan='1' rowspan='1' char='.' align='char'>76.9 (70–81)</td><td colspan='1' rowspan='1' char='.' align='char'>0.613</td><td colspan='1' rowspan='1' char='.' align='char'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Women</td><td colspan='1' rowspan='1' char='.' align='char'>72 (55.8)</td><td colspan='1' rowspan='1' char='.' align='char'>50 (64.9)</td><td colspan='1' rowspan='1' char='.' align='char'>0.195</td><td colspan='1' rowspan='1' char='.' align='char'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Years of education</td><td colspan='1' rowspan='1' char='.' align='char'>8.5 (7–11)</td><td colspan='1' rowspan='1' char='.' align='char'>8.5 (7–11)</td><td colspan='1' rowspan='1' char='.' align='char'>0.613</td><td colspan='1' rowspan='1' char='.' align='char'>27</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MMSE</td><td colspan='1' rowspan='1' char='.' align='char'>23 (22–26)</td><td colspan='1' rowspan='1' char='.' align='char'>24 (23–26)</td><td colspan='1' rowspan='1' char='.' align='char'>0.230</td><td colspan='1' rowspan='1' char='.' align='char'>4</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>AD</td><td colspan='1' rowspan='1' char='.' align='char'>74 (57.4)</td><td colspan='1' rowspan='1' char='.' align='char'>59 (76.6)</td><td colspan='1' rowspan='1' char='.' align='char'><bold>0.005</bold></td><td colspan='1' rowspan='1' char='.' align='char'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>DLB/PDD</td><td colspan='1' rowspan='1' char='.' align='char'>42 (32.6)</td><td colspan='1' rowspan='1' char='.' align='char'>12 (15.6)</td><td colspan='1' rowspan='1' char='.' align='char'><bold>0.007</bold></td><td colspan='1' rowspan='1' char='.' align='char'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>VaD</td><td colspan='1' rowspan='1' char='.' align='char'>9 (7)</td><td colspan='1' rowspan='1' char='.' align='char'>2 (2.6)</td><td colspan='1' rowspan='1' char='.' align='char'>0.216</td><td colspan='1' rowspan='1' char='.' align='char'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>FTD/alcoholic dementia</td><td colspan='1' rowspan='1' char='.' align='char'>4 (3.1)</td><td colspan='1' rowspan='1' char='.' align='char'>4 (5.2)</td><td colspan='1' rowspan='1' char='.' align='char'>0.475</td><td colspan='1' rowspan='1' char='.' align='char'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Mean disease duration (min-max), years</td><td colspan='1' rowspan='1' char='.' align='char'>2.9 (0.5–15)</td><td colspan='1' rowspan='1' char='.' align='char'>2.3 (0.5–12)</td><td colspan='1' rowspan='1' char='.' align='char'><bold>0.045</bold></td><td colspan='1' rowspan='1' char='.' align='char'>13</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' char='.' align='char'>49 (40)</td><td colspan='1' rowspan='1' char='.' align='char'>22 (29)</td><td colspan='1' rowspan='1' char='.' align='char'>0.160</td><td colspan='1' rowspan='1' char='.' align='char'>7</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>CIRS total</td><td colspan='1' rowspan='1' char='.' align='char'>6 (4–8)</td><td colspan='1' rowspan='1' char='.' align='char'>6 (4–7)</td><td colspan='1' rowspan='1' char='.' align='char'>0.311</td><td colspan='1' rowspan='1' char='.' align='char'>2</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Use of antipsychotics</td><td colspan='1' rowspan='1' char='.' align='char'>5 (3.9)</td><td colspan='1' rowspan='1' char='.' align='char'>3 (3.9)</td><td colspan='1' rowspan='1' char='.' align='char'>1.000</td><td colspan='1' rowspan='1' char='.' align='char'>3</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Use of anxiolytics/hypnotics</td><td colspan='1' rowspan='1' char='.' align='char'>20 (15.6)</td><td colspan='1' rowspan='1' char='.' align='char'>8 (10.5)</td><td colspan='1' rowspan='1' char='.' align='char'>0.289</td><td colspan='1' rowspan='1' char='.' align='char'>2</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Use of antidepressants</td><td colspan='1' rowspan='1' char='.' align='char'>43 (33.6)</td><td colspan='1' rowspan='1' char='.' align='char'>23 (30.3)</td><td colspan='1' rowspan='1' char='.' align='char'>0.625</td><td colspan='1' rowspan='1' char='.' align='char'>2</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MADRS</td><td colspan='1' rowspan='1' char='.' align='char'>8 (3.3–12.8)</td><td colspan='1' rowspan='1' char='.' align='char'>5 (3–12.5)</td><td colspan='1' rowspan='1' char='.' align='char'>0.446</td><td colspan='1' rowspan='1' char='.' align='char'>1</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MADRS ≥7</td><td colspan='1' rowspan='1' char='.' align='char'>70 (55)</td><td colspan='1' rowspan='1' char='.' align='char'>33 (43)</td><td colspan='1' rowspan='1' char='.' align='char'>0.135</td><td colspan='1' rowspan='1' char='.' align='char'>1</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MADRS ≥15</td><td colspan='1' rowspan='1' char='.' align='char'>21 (16)</td><td colspan='1' rowspan='1' char='.' align='char'>14 (18)</td><td colspan='1' rowspan='1' char='.' align='char'>0.892</td><td colspan='1' rowspan='1' char='.' align='char'>1</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>APOE∊4 ≥1 allele, fraction (%)</td><td colspan='1' rowspan='1' char='.' align='char'>58/95 (61)</td><td colspan='1' rowspan='1' char='.' align='char'>32/51 (63)</td><td colspan='1' rowspan='1' char='.' align='char'>0.842</td><td colspan='1' rowspan='1' char='.' align='char'>111</td></tr></tbody></table><table-wrap-foot><fn><p>Values are median (IQR) or n (%), unless otherwise indicated.</p><p>VaD = Vascular dementia; FTD = frontotemporal dementia; MMSE: normal range 24–30; CIRS: range 0 (no impairment)–52 (extremely severe impairment); MADRS: normal range 0–6.</p><p>Significant results are shown in bold.</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T2' position='float'><label>Table 2</label><caption><p>Baseline clinical characteristics of non-depressed versus depressed patients (according to the
MADRS score)</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>MADRS baseline &lt;7 (n = 44)</th><th colspan='1' rowspan='1' align='left'>MADRS baseline ≥7 (n = 33)</th><th colspan='1' rowspan='1' align='left'>p value</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Age</td><td colspan='1' rowspan='1' char='.' align='char'>78 (71–81)</td><td colspan='1' rowspan='1' char='.' align='char'>73 (68–80)</td><td colspan='1' rowspan='1' char='.' align='char'><bold>0.049<xref rid='T1F1' ref-type='table-fn'><sup>*</sup></xref></bold></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Women</td><td colspan='1' rowspan='1' char='.' align='char'>29 (66)</td><td colspan='1' rowspan='1' char='.' align='char'>21 (64)</td><td colspan='1' rowspan='1' char='.' align='char'>0.839</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' char='.' align='char'>8 (18)</td><td colspan='1' rowspan='1' char='.' align='char'>14 (44)</td><td colspan='1' rowspan='1' char='.' align='char'><bold>0.030</bold></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Use of antidepressant</td><td colspan='1' rowspan='1' char='.' align='char'>11 (25)</td><td colspan='1' rowspan='1' char='.' align='char'>12 (36)</td><td colspan='1' rowspan='1' char='.' align='char'>0.358</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Use of anxiolytic/hypnotic</td><td colspan='1' rowspan='1' char='.' align='char'>2 (5)</td><td colspan='1' rowspan='1' char='.' align='char'>6 (19)</td><td colspan='1' rowspan='1' char='.' align='char'>0.063</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Use of antipsychotic</td><td colspan='1' rowspan='1' char='.' align='char'>2 (5)</td><td colspan='1' rowspan='1' char='.' align='char'>1 (3)</td><td colspan='1' rowspan='1' char='.' align='char'>1.000</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>CIRS total</td><td colspan='1' rowspan='1' char='.' align='char'>6 (4–7)</td><td colspan='1' rowspan='1' char='.' align='char'>6 (3.5–7.5)</td><td colspan='1' rowspan='1' char='.' align='char'>0.769</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MMSE</td><td colspan='1' rowspan='1' char='.' align='char'>24 (22–25)</td><td colspan='1' rowspan='1' char='.' align='char'>24 (23–26)</td><td colspan='1' rowspan='1' char='.' align='char'>0.268</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Dementia diagnosis (non-AD)</td><td colspan='1' rowspan='1' char='.' align='char'>5 (11)</td><td colspan='1' rowspan='1' char='.' align='char'>13 (39)</td><td colspan='1' rowspan='1' char='.' align='char'><bold>0.007</bold></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>APOE∊4 ≥ 1 allele, fraction (%)</td><td colspan='1' rowspan='1' char='.' align='char'>17/28 (61)</td><td colspan='1' rowspan='1' char='.' align='char'>15/23 (65)</td><td colspan='1' rowspan='1' char='.' align='char'>0.968</td></tr></tbody></table><table-wrap-foot><fn><p>Values are median (IQR) or n (%), unless otherwise indicated.</p><p>MADRS: normal range 0–6; CIRS: range 0 (no impairment)–52 (extremely severe impairment); MMSE: normal range 24–30.</p><p>* Not significant after controlling for centre affiliation. Significant results are shown in bold.</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T3a' position='float'><label>Table 3a</label><caption><p>Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood of a MADRS score of ≥7 at baseline</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal deep WMH ratio</td><td colspan='1' rowspan='1' char='.' align='char'>1.309</td><td colspan='1' rowspan='1' char='.' align='char'>0.536</td><td colspan='1' rowspan='1' char='.' align='char'>0.015</td><td colspan='1' rowspan='1' char='.' align='char'>3.703 (1.294–10.593)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Non-AD versus AD*</td><td colspan='1' rowspan='1' char='.' align='char'>−2.055</td><td colspan='1' rowspan='1' char='.' align='char'>0.666</td><td colspan='1' rowspan='1' char='.' align='char'>0.002</td><td colspan='1' rowspan='1' char='.' align='char'>0.128 (0.035–0.472)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' char='.' align='char'>1.321</td><td colspan='1' rowspan='1' char='.' align='char'>0.611</td><td colspan='1' rowspan='1' char='.' align='char'>0.031</td><td colspan='1' rowspan='1' char='.' align='char'>3.746 (1.130–12.414)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T3b' position='float'><label>Table 3b</label><caption><p>Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a MADRS score of ≥7 at baseline</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total WMH ratio</td><td colspan='1' rowspan='1' char='.' align='char'>0.328</td><td colspan='1' rowspan='1' char='.' align='char'>0.124</td><td colspan='1' rowspan='1' char='.' align='char'>0.008</td><td colspan='1' rowspan='1' char='.' align='char'>1.388 (1.088–1.771)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Non-AD versus AD<xref rid='T3F1' ref-type='table-fn'><sup>*</sup></xref></td><td colspan='1' rowspan='1' char='.' align='char'>–1.841</td><td colspan='1' rowspan='1' char='.' align='char'>0.656</td><td colspan='1' rowspan='1' char='.' align='char'>0.005</td><td colspan='1' rowspan='1' char='.' align='char'>0.159 (0.044–0.574)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' char='.' align='char'>1.300</td><td colspan='1' rowspan='1' char='.' align='char'>0.605</td><td colspan='1' rowspan='1' char='.' align='char'>0.031</td><td colspan='1' rowspan='1' char='.' align='char'>3.671 (1.122–12.006)</td></tr></tbody></table><table-wrap-foot><fn id='T3F1'><label>*</label><p>Non-AD = 0, AD = 1. MADRS: normal range 0–6.</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T4a' position='float'><label>Table 4a</label><caption><p>Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood of a MADRS score of ≥15 at baseline</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal deep WMH ratio</td><td colspan='1' rowspan='1' align='left'>0.855</td><td colspan='1' rowspan='1' align='left'>0.379</td><td colspan='1' rowspan='1' align='left'>0.024</td><td colspan='1' rowspan='1' align='left'>2.350 (1.117–4.943)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' align='left'>1.824</td><td colspan='1' rowspan='1' align='left'>0.672</td><td colspan='1' rowspan='1' align='left'>0.007</td><td colspan='1' rowspan='1' align='left'>6.199 (1.662–23.120)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T4b' position='float'><label>Table 4b</label><caption><p>Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood of a MADRS score of ≥15 at baseline</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal deep WMH ratio</td><td colspan='1' rowspan='1' align='left'>0.985</td><td colspan='1' rowspan='1' align='left'>0.388</td><td colspan='1' rowspan='1' align='left'>0.011</td><td colspan='1' rowspan='1' align='left'>2.678 (1.251–5.733)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Non-AD versus AD*</td><td colspan='1' rowspan='1' align='left'>–1.255</td><td colspan='1' rowspan='1' align='left'>0.682</td><td colspan='1' rowspan='1' align='left'>0.066</td><td colspan='1' rowspan='1' align='left'>0.285 (0.075–1.085)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T4c' position='float'><label>Table 4c</label><caption><p>Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a MADRS score of ≥15 at baseline</p></caption><table rules='all' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total WMH ratio</td><td colspan='1' rowspan='1' align='left'>0.225</td><td colspan='1' rowspan='1' align='left'>0.113</td><td colspan='1' rowspan='1' align='left'>0.046</td><td colspan='1' rowspan='1' align='left'>1.252 (1.004–1.562)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' align='left'>1.781</td><td colspan='1' rowspan='1' align='left'>0.663</td><td colspan='1' rowspan='1' align='left'>0.007</td><td colspan='1' rowspan='1' align='left'>5.939 (1.620–21.769)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T4d' position='float'><label>Table 4d</label><caption><p>Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a MADRS score of ≥15 at baseline</p></caption><table rules='all' frame='hsides'><thead><tr valign='top'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'><sup>p</sup></th><th colspan='1' rowspan='1' align='left'>Odds ratio exp.(B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total WMH ratio (final step)</td><td colspan='1' rowspan='1' align='left'>0.265</td><td colspan='1' rowspan='1' align='left'>0.108</td><td colspan='1' rowspan='1' align='left'>0.014</td><td colspan='1' rowspan='1' align='left'>1.304 (1.055–1.611)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Non-AD versus AD<xref rid='T1F1' ref-type='table-fn'><sup>*</sup></xref> (step 1)</td><td colspan='1' rowspan='1' align='left'>–1.040</td><td colspan='1' rowspan='1' align='left'>0.663</td><td colspan='1' rowspan='1' align='left'>0.116</td><td colspan='1' rowspan='1' align='left'>0.353 (0.096–1.295)</td></tr></tbody></table><table-wrap-foot><fn id='T1F1'><label>*</label><p>Non-AD = 0, AD = 1. MADRS: normal range 0–6.</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T5a' position='float'><label>Table 5a</label><caption><p>Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood of a NPId score of ≥4 at baseline</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal deep WMH ratio</td><td colspan='1' rowspan='1' align='left'>–</td><td colspan='1' rowspan='1' align='left'>–</td><td colspan='1' rowspan='1' align='left'>–</td><td colspan='1' rowspan='1' align='left'>–</td><td colspan='1' rowspan='1' align='left'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' align='left'>1.242</td><td colspan='1' rowspan='1' align='left'>0.591</td><td colspan='1' rowspan='1' align='left'>0.036</td><td colspan='1' rowspan='1' align='left'>3.462 (1.087–11.021)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T5b' position='float'><label>Table 5b</label><caption><p>Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood of a NPId score of ≥4 at baseline</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal deep WMH ratio (final step)</td><td colspan='1' rowspan='1' align='left'>0.703</td><td colspan='1' rowspan='1' align='left'>0.348</td><td colspan='1' rowspan='1' align='left'>0.044</td><td colspan='1' rowspan='1' align='left'>2.019 (1.021–3.993)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Non-AD versus AD* (step 1)</td><td colspan='1' rowspan='1' align='left'>−0.542</td><td colspan='1' rowspan='1' align='left'>0.655</td><td colspan='1' rowspan='1' align='left'>0.408</td><td colspan='1' rowspan='1' align='left'>0.581 (0.161–2.098)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T5c' position='float'><label>Table 5c</label><caption><p>Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a NPId score of ≥4 at baseline</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total WMH ratio</td><td colspan='1' rowspan='1' align='left'>0.275</td><td colspan='1' rowspan='1' align='left'>0.108</td><td colspan='1' rowspan='1' align='left'>0.011</td><td colspan='1' rowspan='1' align='left'>1.317 (1.066–1.628)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Prior depression</td><td colspan='1' rowspan='1' align='left'>1.067</td><td colspan='1' rowspan='1' align='left'>0.632</td><td colspan='1' rowspan='1' align='left'>0.091</td><td colspan='1' rowspan='1' align='left'>2.908 (0.842–10.038)</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T5d' position='float'><label>Table 5d</label><caption><p>Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a NPId score of ≥4 at baseline</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'></th><th colspan='1' rowspan='1' align='left'>B</th><th colspan='1' rowspan='1' align='left'>SE</th><th colspan='1' rowspan='1' align='left'>p</th><th colspan='1' rowspan='1' align='left'>Odds ratio exp. (B) (95% CI)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total WMH ratio (final step)</td><td colspan='1' rowspan='1' align='left'>0.304</td><td colspan='1' rowspan='1' align='left'>0.107</td><td colspan='1' rowspan='1' align='left'>0.005</td><td colspan='1' rowspan='1' align='left'>1.356 (1.099–1.673)</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Non-AD versus AD<xref rid='T5F1' ref-type='table-fn'><sup>*</sup></xref> (step 1)</td><td colspan='1' rowspan='1' align='left'>−0.348</td><td colspan='1' rowspan='1' align='left'>0.686</td><td colspan='1' rowspan='1' align='left'>0.612</td><td colspan='1' rowspan='1' align='left'>0.706 (0.184–2.709)</td></tr></tbody></table><table-wrap-foot><fn id='T5F1'><label>*</label><p>Non-AD = 0, AD = 1. MADRS: normal range 0-6.</p></fn></table-wrap-foot></table-wrap></floats-group></article></PAPER>